Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / American Depository Shares
-
Shares outstanding
-
1,786,081
-
Total 13F shares
-
335,749
-
Share change
-
+132,516
-
Total reported value
-
$2,236,216
-
Price per share
-
$6.75
-
Number of holders
-
8
-
Value change
-
+$889,886
-
Number of buys
-
7
Institutional Holders of KAZIA THERAPEUTICS LTD - American Depository Shares (KZIA) as of Q3 2020
As of 30 Sep 2020,
KAZIA THERAPEUTICS LTD - American Depository Shares (KZIA) was held by
8 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
335,749 shares.
The largest 8 holders included
MORGAN STANLEY, RENAISSANCE TECHNOLOGIES LLC, TRUIST FINANCIAL CORP, HighPoint Advisor Group LLC, WELLS FARGO & COMPANY/MN, UBS Group AG, ACADIAN ASSET MANAGEMENT LLC, and BREWIN DOLPHIN LTD.
This page lists
8
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.